![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Rose M.L. Paulik M.A. Lenhard J.M.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.9, Iss.9, 1999-09, pp. : 1223-1236
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Repaglinide: A Review of its Therapeutic Use in Type 2 Diabetes Mellitus
Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Miglitol: A Review of its Therapeutic Potential in Type 2 Diabetes Mellitus
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Linagliptin: In Type 2 Diabetes Mellitus
Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. :